Letter to the Editor
Sublingual Feverfew/Ginger (LipiGesic M) Reanalysis of Data
- Conflict of Interest: Roger Cady has served as a consultant for GlaxoSmithKline, Merck, and Ortho-McNeil, and received research grants from Allergan, Endo Pharmaceuticals, GlaxoSmithKline, Merck, PuraMed Bioscience, and Wyeth. Authors Daniel Serrano, Richard Lipton, and Rebecca Browning have nothing to disclose in relation to this letter to the editor.
No abstract is available for this article.